Martek Acquires OmegaTech
Martek Biosciences Corporations, Columbia, MD, has signed a definitive agreement to acquire OmegaTech, Boulder, CO. The purchase price of the acquisition is approximately $1.8 million shares of Martek common stock with a current market value of approximately $50 million. As a result of the acquisition, four OmegaTech executives will become Martek officers. Mark Braman will become executive vice president of Martek, Dr. James Flatt will become senior vice president of research and devel opment, Robert Driver will become vice president of manufacturing and Robert Di Scipio will become vice president and associate general counsel of Martek upon completion of the merger.